Data as of 12:06pm ET
| +0.2495 / +4.61%|
The 2 analysts offering 12-month price forecasts for Biocept Inc have a median target of 15.00, with a high estimate of 16.00 and a low estimate of 14.00. The median estimate represents a +165.02% increase from the last price of 5.66.
The current consensus among 2 polled investment analysts is to Buy stock in Biocept Inc. This rating has held steady since July, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.